Literature DB >> 11448324

Unilateral or asymmetric pseudoexfoliation syndrome? An ultrastructural study.

T Hammer1, U Schlötzer-Schrehardt, G O Naumann.   

Abstract

BACKGROUND: Clinically, most patients with pseudoexfoliation (PEX) syndrome reveal only unilateral ocular involvement. However, the generalized nature of the disorder suggests that PEX syndrome is clinically asymmetric rather than strictly unilateral.
OBJECTIVE: To perform an ultrastructural study of the contralateral eyes in patients with unilateral PEX syndrome.
METHODS: Five pairs of donor eyes with slitlamp microscopic, macroscopic, and light microscopic evidence of unilateral PEX syndrome and 6 normal control eyes were investigated by transmission electron microscopy and light and electron microscopic immunohistochemistry using antibodies against the human natural killer (HNK-1) epitope and against latent transforming growth factor beta1-binding protein, both markers for the identification of PEX deposits.
RESULTS: Ultrastructural alterations were observed in anterior segment tissues of all apparently not involved fellow eyes. These included (1) deposits of typical PEX fibrils on the iris and ciliary epithelia and in the dilator muscle of the iris; (2) increased accumulation of extracellular matrix, including microfibrils and reduplicated basement membrane material in the periphery of iris vessels, in the dilator muscle and in the juxtacanalicular tissue of the trabecular meshwork; and (3) degenerative changes of the iris pigment epithelium and dilator muscle cells. Latent transforming growth factor beta1-binding protein- and HNK-1-positive deposits indicating PEX material accumulations were detected in the periphery of iris vessels and in the dilator muscle in all affected and contralateral eyes, but not in the control eyes.
CONCLUSIONS: These subclinical alterations of contralateral eyes in clinically so-called unilateral PEX syndrome support the concept that PEX syndrome is a generalized basically bilateral disorder with a clinically marked asymmetric manifestation. The iris changes may account for the clinical signs characteristic of early stages, such as melanin dispersion, peripupillary atrophy, trabecular meshwork pigmentation, and insufficient asymmetric mydriasis. The findings should be considered in the clinical management of the patients. CLINICAL RELEVANCE: In view of the fact that PEX syndrome is the most common identifiable cause of open-angle glaucoma worldwide and as it is an important risk factor for a wide spectrum of ocular complications, particularly during cataract surgery, the potential involvement of both eyes in the PEX process is of clinical significance.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11448324     DOI: 10.1001/archopht.119.7.1023

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  27 in total

1.  Scanning laser ophthalmoscopic parameters of eyes with exfoliation syndrome.

Authors:  Ali Bulent Cankaya; Emrullah Beyazyildiz
Journal:  Jpn J Ophthalmol       Date:  2010-08-11       Impact factor: 2.447

2.  Hemodynamic evaluation of the posterior ciliary circulation in exfoliation syndrome and exfoliation glaucoma.

Authors:  Efstathios T Detorakis; Athanassios K Achtaropoulos; Eleni E Drakonaki; Vassilios P Kozobolis
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-11-17       Impact factor: 3.117

3.  Pseudoexfoliation syndrome: analysis of systemic comorbidities of 325 PEX-positive patients compared with 911 PEX-negative patients.

Authors:  Elizabeth Scharfenberg; Franziska G Rauscher; Petra Meier; Dirk Hasenclever
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-08-16       Impact factor: 3.117

4.  Evaluation of choroidal thickness using enhanced depth imaging by spectral-domain optical coherence tomography in patients with pseudoexfoliation syndrome.

Authors:  F C Eroglu; L Asena; C Simsek; A Kal; G Yılmaz
Journal:  Eye (Lond)       Date:  2015-03-27       Impact factor: 3.775

5.  Proinflammatory cytokines are involved in the initiation of the abnormal matrix process in pseudoexfoliation syndrome/glaucoma.

Authors:  Matthias Zenkel; Piotr Lewczuk; Anselm Jünemann; Friedrich E Kruse; Gottfried O H Naumann; Ursula Schlötzer-Schrehardt
Journal:  Am J Pathol       Date:  2010-04-15       Impact factor: 4.307

6.  Microarray analysis of iris gene expression in mice with mutations influencing pigmentation.

Authors:  Colleen M Trantow; Tryphena L Cuffy; John H Fingert; Markus H Kuehn; Michael G Anderson
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-01-05       Impact factor: 4.799

7.  Clusterin and complement activation in exfoliation glaucoma.

Authors:  Ivo Doudevski; Agueda Rostagno; Mary Cowman; Jeffrey Liebmann; Robert Ritch; Jorge Ghiso
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-04-17       Impact factor: 4.799

8.  Directed therapy for exfoliation syndrome.

Authors:  Allison Angelilli; Robert Ritch
Journal:  Open Ophthalmol J       Date:  2009-09-17

9.  Directed Therapy: An Approach to the Improved Treatment of Exfoliation syndrome.

Authors:  Allison Angelilli; Robert Ritch
Journal:  Middle East Afr J Ophthalmol       Date:  2009-01

10.  Noncontact in vivo confocal laser scanning microscopy of exfoliation syndrome.

Authors:  Zaher Sbeity; Pat-Michael Palmiero; Celso Tello; Jeffrey M Liebmann; Robert Ritch
Journal:  Trans Am Ophthalmol Soc       Date:  2008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.